CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to create a drug screening platform using human pluripotent stem cells and conductive polymers to mimic the cardiac environment. By enhancing the maturation of cardiac cells, it seeks to improve the reliability of drug testing for cardiovascular diseases, ultimately facilitating personalized treatment…
Despite the burden cardiovascular diseases impose on patients and healthcare systems, a curative therapy is lacking.
One of the primary limitations is the ineffectiveness of current drug testing methods, which rely on individual cells or animal models.
These systems lack the necessary reliability, as shown by the high rate of attrition that additionally increases the cost of drug development.
Although cell reprogramming technology has been suggested as a potential solution that opens the path to…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
